{"disease":{"id":"blood","name":"blood"},"drugs":{"marketed":[{"drug_id":"nyvepria","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"Pegfilgrastim-Apgf","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor on hematopoietic cells","drug_class":"Colony-stimulating factor","quality_score":10,"revenue":"1200","mechanism":"Colony-stimulating factor binding hematopoietic cell surface receptors to stimulate proliferation and differentiation."},{"drug_id":"sapropterin","indication_name":"Reduce blood phenylalanine levels in PKU","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kuvan","generic_name":"SAPROPTERIN","company_name":"BioMarin","drug_phase":"marketed","molecular_target":"Nitric oxide synthase, brain","drug_class":"Phenylalanine Hydroxylase Activator","quality_score":62,"revenue":"300","mechanism":"Kuvan works by activating the enzyme Phenylalanine Hydroxylase to break down phenylalanine."},{"drug_id":"red-blood-cells","indication_name":"Blood Pool Imaging","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Red blood cells","company_name":"McMaster University","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"meclofenamic-acid","indication_name":"Idiopathic Heavy Menstrual Blood Loss","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Meclofenamate","generic_name":"MECLOFENAMIC ACID","company_name":"","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"meclofenamic acid","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"xenon-133xe-gas","indication_name":"Cerebral Blood Flow Assessment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xe 133","generic_name":"xenon (133Xe) gas","company_name":"Mallinckrodt","drug_phase":"marketed","molecular_target":"","drug_class":"Inhalation Diagnostic Agent [EPC]","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"angiotensinamide","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"angiotensinamide","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"angiotensinamide","quality_score":null,"revenue":null,"mechanism":"Angiotensinamide works by increasing blood pressure through a complex interaction with the renin-angiotensin system."},{"drug_id":"xarelto","indication_name":"Prevention of stroke caused by a clot in a blood vessel in the brain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"xarelto","indication_name":"Prevention of systemic embolism caused by a clot in a blood vessel","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"imetelstat","indication_name":"low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rytelo","generic_name":"IMETELSTAT","company_name":"Geron","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":50,"revenue":null,"mechanism":"Rytelo works by inhibiting the activity of telomerase, an enzyme that helps cancer cells grow and divide."},{"drug_id":"dopamine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dopamine Hydrochloride","generic_name":"DOPAMINE","company_name":"","drug_phase":"marketed","molecular_target":"D(1A) dopamine receptor","drug_class":"Catecholamine","quality_score":10,"revenue":null,"mechanism":"Dopamine Hydrochloride works by stimulating dopamine receptors in the body to increase heart rate, blood pressure, and cardiac output."},{"drug_id":"metaraminol","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aramine","generic_name":"METARAMINOL","company_name":"","drug_phase":"marketed","molecular_target":"Macrophage migration inhibitory factor","drug_class":"Indirectly Acting Sympathomimetic Amines","quality_score":21,"revenue":null,"mechanism":""},{"drug_id":"rivaroxaban","indication_name":"Prevention of stroke caused by a clot in a blood vessel in the brain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."},{"drug_id":"rivaroxaban","indication_name":"Prevention of systemic embolism caused by a clot in a blood vessel","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."},{"drug_id":"multihance-0-1-mmol-kg","indication_name":"MRI of the central nervous system (CNS) in adults and pediatric patients (including term neonates) to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine, and associated tissues","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MultiHance 0.1 mmol/kg","company_name":"Bracco Diagnostics, Inc","drug_phase":"marketed","molecular_target":"Water protons in tissue; blood-brain barrier; vascular endothelium","drug_class":"Paramagnetic contrast agent; gadolinium-based MRI contrast medium","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"prazosin-hcl","indication_name":"Lowering blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prazosin Hcl","generic_name":"prazosin-hcl","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 1D","drug_class":"prazosin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"levophed","indication_name":"Blood pressure restoration in adult patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levophed","generic_name":"Norepinephrine Bitartrate","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-adrenergic and beta-adrenergic receptors","drug_class":"Catecholamine, sympathomimetic amine","quality_score":10,"revenue":null,"mechanism":"Peripheral vasoconstrictor via alpha-adrenergic action and cardiac inotropic stimulator with coronary vasodilation via beta-adrenergic action."},{"drug_id":"buphenine","indication_name":"Disorder of blood vessel","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Buphenin","generic_name":"buphenine","company_name":"","drug_phase":"unknown","molecular_target":"Adrenergic receptor alpha-1","drug_class":"buphenine","quality_score":null,"revenue":null,"mechanism":"Buphenine works by stimulating the alpha-1 adrenergic receptors, which helps to constrict blood vessels and improve blood flow."},{"drug_id":"pegfilgrastim-jmdb","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULPHILA","generic_name":"PEGFILGRASTIM-JMDB","company_name":"MYLAN GMBH","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"epinephrine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"norepinephrine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norepinephrine Bitartrate In 5% Dextrose","generic_name":"NOREPINEPHRINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"alpha-adrenergic receptors, beta-adrenergic receptors","drug_class":"Catecholamine","quality_score":80,"revenue":null,"mechanism":"Norepinephrine constricts blood vessels and stimulates the heart."},{"drug_id":"pegfilgrastim","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"PEGFILGRASTIM","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":70,"revenue":null,"mechanism":"Neulasta stimulates the production of white blood cells by binding to their receptors."},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"tolazoline","indication_name":"Disorder of blood vessel","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vasodil","generic_name":"TOLAZOLINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"tolazoline","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"mephentermine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vialin","generic_name":"MEPHENTERMINE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"Indirectly Acting Sympathomimetic Amines","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"methoxamine","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methoxamin","generic_name":"METHOXAMINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor","drug_class":"methoxamine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"aprocitentan","indication_name":"High blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tryvio","generic_name":"APROCITENTAN","company_name":"Idorsia","drug_phase":"marketed","molecular_target":"","drug_class":"Endothelin Receptor Antagonist [EPC]","quality_score":60,"revenue":null,"mechanism":"Tryvio works by blocking the action of endothelin, a protein that constricts blood vessels and increases blood pressure."},{"drug_id":"treosulfan","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Trecondi","generic_name":"TREOSULFAN","company_name":"Medexus","drug_phase":"marketed","molecular_target":"","drug_class":"treosulfan","quality_score":48,"revenue":null,"mechanism":""},{"drug_id":"indocyanine-green","indication_name":"Evaluation of vascular and tissue blood flow","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spy Agent Green Kit","generic_name":"INDOCYANINE GREEN","company_name":"Renew Pharms","drug_phase":"marketed","molecular_target":"","drug_class":"Diagnostic Dye","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"clopidogrel","indication_name":"Prevention blood clots forming in hardened blood vessels","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plavix","generic_name":"clopidogrel","company_name":"Generic (originally Sanofi/BMS)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter","drug_class":"Thienopyridine antiplatelet agent","quality_score":55,"revenue":null,"mechanism":"Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis."},{"drug_id":"clopidogrel","indication_name":"Prevention of blood clots after heart attack or stroke","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Plavix","generic_name":"clopidogrel","company_name":"Generic (originally Sanofi/BMS)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2B6, P2Y purinoceptor 12, Sodium-dependent serotonin transporter","drug_class":"Thienopyridine antiplatelet agent","quality_score":55,"revenue":null,"mechanism":"Irreversibly blocks the P2Y12 ADP receptor on platelets, inhibiting platelet aggregation and preventing arterial thrombosis."},{"drug_id":"neulasta","indication_name":"Allogeneic peripheral blood stem cell transplant","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neulasta","company_name":"Columbia University","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adenine","indication_name":"Whole Blood Collection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin B4","generic_name":"ADENINE","company_name":"","drug_phase":"marketed","molecular_target":"Phosphatidylinositol 4-kinase, PI4K, Leucine-rich repeat serine/threonine-protein kinase 2, Xanthine dehydrogenase/oxidase","drug_class":"Calculi Dissolution Agent [EPC]","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"noradrenaline","indication_name":"Low blood pressure","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Noradrenaline","company_name":"Tanta University","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"adenine","indication_name":"Blood Component Processing","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin B4","generic_name":"ADENINE","company_name":"","drug_phase":"marketed","molecular_target":"Phosphatidylinositol 4-kinase, PI4K, Leucine-rich repeat serine/threonine-protein kinase 2, Xanthine dehydrogenase/oxidase","drug_class":"Calculi Dissolution Agent [EPC]","quality_score":24,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":35,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04410458","title":"Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）","phase":"NA","overall_status":"UNKNOWN","enrollment_count":506517,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT04370886","title":"Recruit Blood Donors Via SMS During Epidemic of COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":456517,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT04431180","title":"Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#","phase":"NA","overall_status":"UNKNOWN","enrollment_count":403535,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT03954119","title":"Blood Pressure in the Emergency Department","phase":"","overall_status":"COMPLETED","enrollment_count":300272,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT06820515","title":"ATHNdataset Registry","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200000,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT03521739","title":"Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT05095844","title":"National Vaccine Adverse Event Reporting Survey and Etiology","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Neuroganics LLC","has_results":false},{"nct_id":"NCT04226612","title":"Association of Inpatient Blood Pressure Levels With In-hospital Adverse Events(APPLE Study)","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT07094295","title":"Perioperative Blood Transfusion and Increased One-year Mortality","phase":"","overall_status":"COMPLETED","enrollment_count":97443,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT05814068","title":"Active Screening of Arterial Hypertension by Community Outreach Workers in the Cayenne Metropolitan Area to Reduce the Incidence of Cardiovascular Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50000,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT06403163","title":"Transfusion Surveillance in Anaesthesia","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Erasme University Hospital","has_results":false},{"nct_id":"NCT05030467","title":"Leveraging Electronic Health Record (EHR) Tools to Reduce Health Disparities for Patients With Uncontrolled Hypertension","phase":"NA","overall_status":"COMPLETED","enrollment_count":49210,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":true},{"nct_id":"NCT05698433","title":"Development of a Prediction Model for Intraoperative Blood Pressure Variability","phase":"","overall_status":"COMPLETED","enrollment_count":47520,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT07082322","title":"European Prospective Bloodstream Infection Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40000,"lead_sponsor_name":"University Hospital Freiburg","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06138899","title":"Enhancing Blood Donation at Schools and Beyond in Malawi","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":35000,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03578419","title":"Small-Volume Tubes to Reduce Anemia and Transfusion","phase":"NA","overall_status":"COMPLETED","enrollment_count":27411,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT04466059","title":"Better Leukemia Diagnostics Through AI (BELUGA)","phase":"","overall_status":"RECRUITING","enrollment_count":25000,"lead_sponsor_name":"Munich Leukemia Laboratory","has_results":false},{"nct_id":"NCT04306055","title":"Blood Donor Recruitment During Epidemic of COVID-19","phase":"NA","overall_status":"COMPLETED","enrollment_count":19491,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT05485051","title":"Daily Chlorexidine Bath for Health Care Associated Infection Prevention","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":15730,"lead_sponsor_name":"Hospital do Coracao","has_results":false},{"nct_id":"NCT06670677","title":"Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Aktiia SA","has_results":false},{"nct_id":"NCT03147092","title":"Matão Controlling Hypertension (MatCH Study): Rationale and Design","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":15000,"lead_sponsor_name":"Centro Neurológico de Pesquisa e Reabiitação, Brazil","has_results":false},{"nct_id":"NCT04078893","title":"The Effect of Recruiting Inactive Blood Donors Using Different Means","phase":"NA","overall_status":"UNKNOWN","enrollment_count":14098,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT04561050","title":"Prediction of Massive Transfusion in Trauma Patients","phase":"","overall_status":"COMPLETED","enrollment_count":13222,"lead_sponsor_name":"Centre Hospitalier Universitaire Vaudois","has_results":false},{"nct_id":"NCT03808311","title":"Blood Pressure Control Target in Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":12821,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT02984384","title":"PREVENTion of Clot in Orthopaedic Trauma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12424,"lead_sponsor_name":"Major Extremity Trauma Research Consortium","has_results":true},{"nct_id":"NCT03047369","title":"The Myelin Disorders Biorepository Project","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT03366441","title":"Reactivation of Inactive Blood Donors","phase":"NA","overall_status":"COMPLETED","enrollment_count":11880,"lead_sponsor_name":"Guangzhou Blood Center","has_results":false},{"nct_id":"NCT04827615","title":"Evaluation of the Ambuja Cement Foundation Noncommunicable Disease Program in Bathinda District of Punjab, India","phase":"NA","overall_status":"COMPLETED","enrollment_count":11322,"lead_sponsor_name":"Harvard School of Public Health (HSPH)","has_results":false},{"nct_id":"NCT06840756","title":"Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":11082,"lead_sponsor_name":"Michelle Zeller","has_results":false},{"nct_id":"NCT00552214","title":"Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens","phase":"NA","overall_status":"COMPLETED","enrollment_count":10290,"lead_sponsor_name":"Novartis","has_results":false},{"nct_id":"NCT05858944","title":"Home Blood Pressure Intervention in the Community Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Shanghai Institute of Hypertension","has_results":false},{"nct_id":"NCT07406074","title":"Duke Virtual IntEgrated Workflow","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03547856","title":"A Registry Study on the \"Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients\"","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Yan Li","has_results":false},{"nct_id":"NCT06418048","title":"INfectious DIsease REgistry BIObank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03282747","title":"Distribution of Risk Factors for Venous Thromboembolism in Blood Donors","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Casa Sollievo della Sofferenza IRCCS","has_results":false},{"nct_id":"NCT03848962","title":"Collection and Distribution of Biospecimens for Novel Research Uses","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"iSpecimen Inc","has_results":false},{"nct_id":"NCT04040634","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9476,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT02815605","title":"Risk Factors, Management and Complications of Severe Post-partum Hemorrhage","phase":"","overall_status":"COMPLETED","enrollment_count":9000,"lead_sponsor_name":"Tampere University Hospital","has_results":false},{"nct_id":"NCT03344887","title":"An Innovative Trial Assessing Donor Sex on Recipient Mortality","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":8850,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT06085690","title":"Multicenter Clinical Translational Study of \"ICU-NO CRBSI\" Based on Improvement Science","phase":"NA","overall_status":"RECRUITING","enrollment_count":8050,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06427096","title":"Effect of Healthy Family Program on Population Blood Pressure","phase":"NA","overall_status":"COMPLETED","enrollment_count":8001,"lead_sponsor_name":"Heart Health Research Center","has_results":false},{"nct_id":"NCT02598609","title":"SEPREVEN: a Stepped-wedge Randomised Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"Dr Caeymaex Laurence","has_results":false},{"nct_id":"NCT03786705","title":"Delta Shock Index in Predicting Massive Transfusion","phase":"","overall_status":"COMPLETED","enrollment_count":7957,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05992415","title":"Know Your Pressures NYC","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7085,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT04548167","title":"Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital Infection","phase":"","overall_status":"COMPLETED","enrollment_count":7064,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT05919966","title":"The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units","phase":"","overall_status":"COMPLETED","enrollment_count":6930,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03379688","title":"PDMS Outcome After Intensive Care, Organdysfunction and Monitoring","phase":"","overall_status":"COMPLETED","enrollment_count":6909,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}